Conserved type III secretion system exerts important roles in Chlamydia trachomatis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5404-5414

  Dai, Wenting ^a   Li, Zhongyu ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Chaperones; Chlamydia trachomatis; Effectors; Injectisomes; Regulators; Type III secretion system

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL SECRETION SYSTEM; CHAPERONE; VIRULENCE FACTOR;

ANIMAL; BACTERIAL SECRETION SYSTEM; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULAR EVOLUTION; PATHOGENICITY; PROTEIN TRANSPORT; SECRETION (PROCESS); VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR CHAPERONES; PROTEIN TRANSPORT; VIRULENCE; VIRULENCE FACTORS;

EID: 84911472000     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Omsland A, Sager J, Nair V, Sturdevant DE and Hackstadt T. Developmental stage specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium. Proc Natl Acad Sci U S A 2012; 109: 19781-19785.
2. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA and Hackstadt T. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 2004; 101: 10166-10171.
3. Belland R, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL and Caldwell HD. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 2003; 100: 8478-8483.
4. Dumoux M, Clare DK, Sabibil HR and Hayward RD. Chlamydiae assemble a pathogen synapse to hijack the host endoplasmic reticulum. Traffic 2012; 13: 1612-1627.
5. Saka HA, Thompson JW, Chen YS, Kumar Y, Dubois LG, Moseley MA and Valdivia RH. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms. Mol Microbiol 2011; 82: 1185-1203.
6. Betts HJ, Twiggs LE, Sal MS, Wyrick PB and Fields KA. Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis. J Bacteriol 2008; 190: 1680-1690.
7. Betts-Hampikian HJ and Fields KA. Disulfide Bonding within Components of the Chlamydia Type III Secretion Apparatus Correlates with Development. J Bacteriol 2011; 193: 6950-6959.
8. Sun P, Tropea JE, Austin BP, Cherry S and Waugh DS. Structural characterization of the Yersiniapestis type III secretion system needle protein YscF in complex with its heterodimeric chaperone YscE/YscG. J Mol Biol 2008; 377: 819-830.
9. Subtil A, Blocker A and Dautry-Varsat A. Type III secretion system in Chlamydia species: identified members and candidates. Microbes Infect 2000; 2: 367-369.
10. Brinkworth AJ, Malcolm DS, Pedrosa AT, Roguska K, Shahbazian S, Graham JE, Hayward RD and Carabeo RA. Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP. Mol Microbiol 2011; 82: 131-144.
11. Chen YS, Bastidas RJ, Saka HA, Carpenter VK, Richards KL, Plano GV and Valdivia RH. The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling. PLoS Pathog 2014; 10: e1003954.
12. Pennini ME, Perrinet S, Dautry-Varsat A and Subtil A. Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis. PLoS Pathog 2010; 6: e10000995.
13. Chellas-Gery B, Linton CN and Fields KA. Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell Microbiol 2007; 9
14. Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL and Starnbach MN. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 2006; 61: 142-150.
15. Le Negrate G, Krieg A, Faustin B, Loeffler M, Godzik A, Krajewski S and Reed JC. ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits IkappaBalpha ubiquitination and degradation. Cell Microbiol 2008; 10: 1879-1892.
16. Pais SV, Milho C, Almeida F and Mota LJ. Identification of Novel Type III Secretion Chaperone-Substrate Complexes of Chlamydia trachomatis. PLoS One 2013; 8: e56292.
17. Fling SP, Sutherland RA, Steele LN, Hess B, D'Orazio SE, Maisonneuve J, Lampe MF, Probst P and Starnbach MN. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci U S A 2001; 98:1160-1165.
18. Muschiol S, Boncompain G, Vromman F, Dehoux P, Normark S, Henriques-Normark B and Subtil A. Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae. Infect Immun 2011; 79: 571-580.
19. Hobolt-Pederson AS, Christiansen G, Timm-erman E, Gevaert K and Birkelund S. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol Med Microbiol 2009; 57: 46-58.
20. Gong S, Lei L, Chang X, Belland R and Zhong G. Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Microbiology 2011; 157: 1134-1144.
21. Hower S, Wolf K and Fields KA. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 2009; 72: 1423-1437.
22. Kumar Y, Cocchiaro J and Valdivia RH. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 2006; 16: 1646-1651.
23. da Cunha M, Milho C, Almeida F, Pais SV, Borges V, Maurício R, Borrego MJ, Gomes JP and Mota LJ. Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system. BMC Microbiol 2014; 14: 40.
24. Subtil A, Delevoye C, Balañá ME, Tastevin L, Perrinet S and Dautry-Varsat A. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 2005; 56: 1636-1647.
25. Jewett TJ, Fischer ER, Mead DJ and Hackstadt T. Chlamydial TARP is a bacterial nucleator of actin. Proc Natl Acad Sci U S A 2006; 103: 15599-15604.
26. Jiwani S, Ohr RJ, Fischer ER, Hackstadt T, Alvarado S, Romero A and Jewett TJ. Chlamydia trachomatis Tarp cooperates with the Arp2/3 complex to increase the rate of actin polymerization. Biochem Biophys Res Commun 2012; 420: 816-821.
27. Jewett TJ, Dooley CA, Mead DJ and Hackstadt T. Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases. Biochem Biophys Res Commun 2008; 371: 339-344.
28. Wang J, Zhang Y, Yu P, and Zhong G. Immu-nodominant Regions of a Chlamydia trachomatis Type III Secretion Effector Protein, Tarp. Clin Vaccine Immunol 2010; 17: 1371-1376.
29. Wang J, Chen L, Chen F, Zhang X, Zhang Y, Baseman J, Perdue S, Yeh IT, Shain R, Holland M, Bailey R, Mabey D, Yu P and Zhong G. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine 2009; 27: 2967-2980.
30. Carabeo RA, Grieshaber SS, Hasenkrug A, Dooley C and Hackstadt T. Requirement for the Rac GTPase in Chlamydia trachomatis invasion of non-phagocytic cells. Traffic 2004; 5: 418-425.
31. Lane BJ, Mutchler C, Al Khodor S, Grieshaber SS and Carabeo RA. Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. PLoS Pathog 2008; 4: e1000014.
32. Bullock HD, Hower S and Fields KA. Domain analyses reveal that C. trachomatis CT694 belongs to the membrane-localized family of type III effector proteins. J Biol Chem 2012; 287: 28078-28086.
33. Derre I, Swiss R and Agaisse H. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog 2011; 7: e1002092.
34. Rzomp KA, Moorhead AR and Scidmore MA. The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun 2006; 74: 5362-5373.
35. Suchland RJ, Rockey DD, Bannantine JP and Stamm WE. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun 2000; 68: 360-367.
36. Mital J, Miller NJ, Fischer ER and Hackstadt T. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell Microbiol 2010; 12: 1235-1249.
37. Derre I, Swiss R and Agaisse H. The Lipid Transfer Protein CERT Interacts with the Chla-mydia Inclusion Protein IncD and Participates to ER Chlamydia Inclusion Membrane Contact Sites. PLoS Pathog 2011; 7: e1002092.
38. Scidmore MA and Hackstadt T. Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol 2001; 39: 1638-1650.
39. Ronzone E and Paumet F. Two Coiled-Coil Domains of Chlamydia trachomatis IncA Affect Membrane Fusion Events during Infection. PLoS One 2013; 8: e69769.
40. Birge RB, Kalodimos C, Inagaki F and Tanaka S. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal 2009; 7: 13.
41. Hobolt-Pedersen AS, Christiansen G, Timmer-man E, Gevaert K and Birkelund S. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol Med Microbiol 2009; 57: 46-58.
42. Thomas NA, Ma I, Prasad ME and Rafuse C. Expanded roles for multicargo and class 1B effector chaperones in type III secretion. J Bacteriol 2012; 194: 3767-3773.
43. Brinkworth AJ, Malcolm DS, Pedrosa AT, Roguska K, Shahbazian S, Graham JE, Hayward RD and Carabeo RA. Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP. Mol Microbiol 2011; 82: 131-144.
44. Pais SV, Milho C, Almeida F and Mota LJ. Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis. PLoS One 2013; 8: e56292.
45. Spaeth KE, Chen YS and Valdivia RH. The Chlamydia type III secretion system C-ring en gages a chaperone-effector protein complex. PLoS Pathog 2009; 5: e1000579.
46. Samudrala R, Heffron F and McDermott JE. Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog 2009; 5: e1000375.
47. Markham AP,Jaafar ZA, Kemege KE, Middaugh CR and Hefty PS. Biophysical characterization of Chlamydia trachomatis CT584 supports its potential role as a type III secretion needle tip protein. Biochemistry 2009; 48: 10353-10361.
48. Fields KA, Fischer ER, Mead DJ and Hackstadt T. Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J Bacteriol 2005; 187: 6466-6478.
49. Spaeth KE, Chen YS and Valdivia RH. The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex. PLoS Pathog 2009; 5: e1000579.
50. Betts HJ, Twiggs LE, Sal MS, Wyrick PB and Fields KA. Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis. J Bacteriol 2008; 190: 1680-1690.
51. Cornelis GR. The type III secretion injectisome. Nat Rev Microbiol 2006; 4: 811-825.
52. Francis MS, Wolf-Watz H and Forsberg A. Regulation of type III secretion systems. Curr Opin Microbiol 2002; 5: 166-172.
53. Muschiol S, Normark S, Henriques-Normark B and Subtil A. Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells. BMC Microbiol 2009; 9: 75.
54. Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR and Clarke IN. Development of a Transformation System for Chlamydia trachomatis: Restoration of Glycogen Biosynthesis by Acquisition of a Plasmid Shuttle Vector. PLoS Pathog 2011; 7: e1002258.